Tag: Incyte

With a significant presence in the biopharmaceutical industry, Incyte has developed a diverse portfolio of treatments aimed at areas of high unmet medical need, particularly oncology, inflammation, and dermatology. Understanding what drugs does Incyte make involves exploring their proprietary therapies as well as co-marketed and licensed products.

With an average retail price exceeding $2,300 for a single 60g tube without insurance, understanding why does Opzelura cost so much is a major concern for many patients. This high price tag stems from a complex mix of factors inherent to the pharmaceutical industry, including significant research and development costs, market exclusivity, and specialized manufacturing.

The Wholesale Acquisition Cost (WAC) for a 60-count bottle of Jakafi (ruxolitinib) is approximately $17,600, though a patient's actual cost depends heavily on their specific insurance plan and financial assistance programs. Because it is a specialty medication, the question, 'how much does Jakafi cost in the US?' involves navigating a complex landscape of pricing, insurance coverage, and manufacturer-sponsored aid.